AGCKNFFWKTFTSC (DISULFIDE BRIDGE: 3-14), ACETATE SALT
AGCKNFFWKTFTSC (DISULFIDE BRIDGE: 3-14), ACETATE SALT Basic information
- Product Name:
- AGCKNFFWKTFTSC (DISULFIDE BRIDGE: 3-14), ACETATE SALT
- Synonyms:
-
- H-ALA-GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS-OH (DISULFIDE BRIDGE: 3-14), ACETATE SALT
- AGCKNFFWKTFTSC (DISULFIDE BRIDGE: 3-14), ACETATE SALT
- SOMATOSTATIN 14, ACETATE
- Somatostatin monoacetate
- GHIH
- Somatostatin (sheep), monoacetate (salt)
- Somatostatin-14 (human, mouse, rat, porcine, bovine, ovine) (acetate)
- Cyclic somatostatin Acetate
- CAS:
- 54472-66-1
- MF:
- C78H108N18O21S2
- MW:
- 1697.95
- Product Categories:
-
- peptide
- Mol File:
- Mol File
AGCKNFFWKTFTSC (DISULFIDE BRIDGE: 3-14), ACETATE SALT Chemical Properties
- storage temp.
- Store at -20°C
- solubility
- Water: 0.3 mg/ml
- form
- A powder
AGCKNFFWKTFTSC (DISULFIDE BRIDGE: 3-14), ACETATE SALT Usage And Synthesis
Description
Somatostatin-14 is a natural cyclic peptide hormone derived from the preprohormone, somatostatin. It is a somatostatin (SST) receptor agonist that binds to SST1, SST2, SST3, SST4, and SST5 (IC50s = 0.22, 0.10, 0.28, 1.23, and 0.30 nM, respectively, in CCL39 cells expressing human recombinant receptors). It inhibits cAMP accumulation induced by forskolin in CCL39 cells expressing human recombinant SST1, SST2, SST3, SST4, and SST5 (EC50s = 6.16, 4.37, 17.38, 2.95, and 4.67 nM, respectively). Somatostatin-14 inhibits the release of growth hormone, prolactin, thyrotropin, glucagon, and insulin, as well as other signaling molecules.
References
[1] D J HADJIDAKIS. Differences between somatostatin-28 and somatostatin-14 with respect to their biological effects in healthy humans and acromegalics.[J]. Clinical physiology and biochemistry, 1986, 4 6: 372-383.
[2] S SIEHLER D H K Seuwen. Characterisation of human recombinant somatostatin receptors. 1. Radioligand binding studies.[J]. Naunyn-Schmiedeberg’s archives of pharmacology, 1999, 360 5: 488-499. DOI: 10.1007/s002109900141
[3] S SIEHLER D H. Characterisation of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activity.[J]. Naunyn-Schmiedeberg’s archives of pharmacology, 1999, 360 5: 510-521. DOI: 10.1007/s002109900143
[4] GILLIES G. Somatostatin: the neuroendocrine story.[J]. Trends in pharmacological sciences, 1997, 18 3: 87-95. DOI: 10.1016/s0165-6147(96)01032-2
[5] IAN M P JOSEPH. A model for integrative study of human gastric acid secretion.[J]. Journal of applied physiology, 2003, 94 4: 1602-1618. DOI: 10.1152/japplphysiol.00281.2002
AGCKNFFWKTFTSC (DISULFIDE BRIDGE: 3-14), ACETATE SALTSupplier
- Tel
- 21-61263452 13641803416
- ymbetter@glbiochem.com
- Tel
- 0731-85526065 13308475853
- ivy@hnhbsj.com
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 025-58361106-805 15951641583
- zhao.xu@njpeptide.com